Skip to main content
TipRanks
Go Ultimate75% OFF

Jenny Harry Insider Profile

4 Followers

Jenny Harry, Director at Neuren Pharmaceuticals Limited, holds 29.66K shares in Neuren Pharmaceuticals Limited (Ticker: NURPF), holds 11.06M shares in Contango Asset Management Ltd. (Ticker: AU:APL). Most recently, Jenny Harry Bought ― shares of Neuren Pharmaceuticals Limited on Oct 08, 2021 for an estimated value of $20.00K.

Jenny Harry's Trading History

NURPF
Neuren Pharmaceuticals Limited
Oct 08, 2021DirectorInformative Buy20.00K$408.16K
APL
Contango Asset Management Ltd.
Feb 18, 2011Senior OfficerUninformative Sell―AU$3.26M

You May Also Like

Jenny Harry insider profile FAQ

What is the percentage of profitable transactions made by Jenny Harry?
The percentage of profitable transactions made by Jenny Harry is 33%.
What is the average return per transaction made by Jenny Harry?
The average return per transaction made by Jenny Harry is 56.90%.
What stocks does Jenny Harry hold?
Jenny Harry holds: NURPF, AU:APL stocks.
What was Jenny Harry’s latest transaction?
Jenny Harry’s latest transaction was an Informative Buy of $20.00K.
What was Jenny Harry's most profitable transaction?
Jenny Harry’s most profitable transaction was an Informative Buy of NURPF stock on October 8, 2021. The return on the trade was 197.60%.
What is Jenny Harry's role in Neuren Pharmaceuticals Limited?
Jenny Harry's role in Neuren Pharmaceuticals Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.